Asheville residents still can’t drink the water from their faucets. And the Helene disaster isn't the first time this has ...
It's the largest Print with a Purpose collection ever from the Palm Beach brand, to benefit an organization with strong ties ...
Creator JJ Abrams struck gold with the hit series Lost, which premiered 20 years ago in September 2004, ushering in the era of 'water cooler' TV, which saw endless discussion about the latest ...
Eli Lilly & Co. Inc. said Tuesday the Japanese regulator has approved its Kisunla treatment for adults with early symptomatic Alzheimer’s disease, including those with mild cognitive impairment ...
Eli Lilly’s two weight loss drugs have become blockbusters, bringing in more than $1 billion in annual revenue. Demand is growing in this market, but so is competition. These players ...
Indian-origin Pulitzer Prize-winning author Jhumpa Lahiri, has declined the prestigious 2024 Isamu Noguchi Award in protest of the Noguchi Museum’s recently implemented dress code policy. Lahiri’s ...
The most recent trading session ended with Eli Lilly (LLY) standing at $909.32, reflecting a -1.65% shift from the previouse trading day's closing. This change lagged the S&P 500's daily gain of 0.4%.
Novo Nordisk and Eli Lilly are expected to rule the obesity market for a few more years without much challenge. To ensure they stay there as competition enters, the companies are spending billions in ...
Happy first week of fall! With the changing season comes a fresh wave of deals on Amazon, especially in the hidden gem that is the Amazon Outlet. Packed with overstock and clearance items ...
"If you want to make something smarter, teach it to play," remarks a trailblazing oceanographer in Richard Powers' Playground. Evelyne Beaulieu is one of several brilliant characters in the novel ...
A onetime business editor at the Detroit Free Press who was part of a team that won a Pulitzer Prize for coverage of the city's 1967 riot and was inducted into the Michigan Journalism Hall of Fame ...
Eli Lilly has become a household name thanks to breakthrough diabetes and obesity care medicines. The stock has trounced the broader market over the past year, and shares have become a bit pricey.